Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors

International Journal of Gynecological Cancer

Volumn 16, Issue 5, 2006, Pages 1918-1926

  El Shalakany, A H ^a,b   Kamel, K M ^a   Ismail, A M ^b   Salah, L ^c   El Deen Fahmy, S S ^b   El Deen Ammar, E ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c BENHA UNIVERSITY   (Egypt)

Author keywords

Receptors; Sex steroids; Telomerase; Trophoblast; tumors

Indexed keywords

BIOTIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTROGEN RECEPTOR; FORMALDEHYDE; PARAFFIN; PEROXIDASE; PROGESTERONE RECEPTOR; STREPTAVIDIN; TELOMERASE;

ABORTION; ADOLESCENT; ADULT; ARTICLE; CATALYSIS; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; ORGAN SIZE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TROPHOBLASTIC TUMOR; TUMOR REGRESSION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHORIOCARCINOMA; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREGNANCY; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TELOMERASE;

EID: 33749154278     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00718.x     Document Type: Article

References (35)

1. Kohorn EI, Goldstein DP, Hancock BW et al. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynecol Cancer 2000;10:84-8.
2. Seckl MJ, Newlands ES. Gestational trophoblastic tumours. In: Shaw RW, Soutter WP, Stanton SL, eds. Gynaecology, 3rd edn. Churchill Livingstone, Edinburgh, UK, 2003:653-64.
3. Benedet JL, Hacker NF, Ngan HYS et al. Staging classifications and clinical practice guidelines of gynaecologic cancers. FIGO Web site, Available at http://www.figo.org/content/PDF/staging-booklet.pdf. Accessed December 9, 2005.
4. Disaia PJ, Creasman WT. Gestational trophoblastic neoplasia. In: Disaia PJ, Creasman WT, editors. Clinical gynecologic oncology, 6th edn. St. Louis, MO: Mosby; 2001:185-92.
5. Genest DR, La Borde O, Berkowitz RS et al. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990). Histologic grade lacks prognostic significance. Obstet Gynecol 1991;78:402-9.
6. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England & Wales 1973-83. Lancet 1986;70:673-7.
7. Curry SL, Schlaerth J, Kohorn EI et al. Hormonal contraception & trophoblastic sequelae after hydatidiform mole. A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1989;160:805-11.
8. Stone M, Dent J, Kardana A, Bagshawe KD. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole. Br J Obstet Gynecol 1976;83:912-6.
9. Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol 1979;86:782-92.
10. Berkowitz RS, Goldstein DP, Marean AR, Bernstein M. Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol 1981;58:474-7.
11. Adewole IF, Oladokun A, Fawole AO, Olawuyi JF, Adeleye JA. Fertility regulatory methods and development of complications after evacuation of complete hydatidiform mole. J Obstet Gynaecol 2000;20:68-9.
12. McCormick PD, Razel AJ, Spelsberg TC et al. Absence of high affinity binding of progesterone (R5020) in human placenta and fetal membranes. Placenta 1981;3(Suppl.):123-32.
13. Khan-Dawood FS, Dawood MY. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol 1984;15:501-5.
14. Rivera J, Cano A. Oestrogen and progesterone receptors in human term placenta. Measurement by binding assays and immunological methods. Placenta 1989;10:579-88.
15. Wang JD, Zhu JB, Fu Y et al. Progesterone receptor immunoreactivity at the maternofetal interface of first trimester pregnancy: a study of the trophoblast population. Hum Reprod 1996;11:413-9.
16. Rossmanith WG, Wolfahrt S, Ecker A, Eberhardt E. The demonstration of progesterone, but not of estrogen, receptors in the developing human placenta. Horm Metab Res 1997;29:604-10.
17. Wake N, Fujino T, Hoshi S. The propensity to malignancy of dispermic heterozygous moles. Placenta 1987;8:319-25.
18. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomere RNA. Cell 2000;100:503-12.
19. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000;18:2626-34.
20. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996;8:66-71.
21. Mutirangura A, Supiyaphun P, Trirekapan S et al. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer 1996;56:3530-3.
22. Shi SR, Key ME, Klara KL. Antigen retrieval in formalin fixed paraffin embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven heating of tissue section. J Histochem Cytochem 1991;39:741-8.
23. Adams EJ, Green JA, Clark AH, Young JH. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 1999;52:75-7.
24. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591-5.
25. Morrow CP. Post-molar trophoblastic disease: diagnosis, management and prognosis. Clin Obstet Gynecol 1984;27:211-20.
26. Vasilev SA, Sclaerth JB, Ahn C et al. Serum progesterone monitoring in postmolar surveillance. Gynecol Oncol 1994;54:288-91.
27. Cheung AN, Ngan HY, Ng WF, Khoo US. The expression of Cathepsin D, oestrogen receptor and progestogen receptor in hydatidiform mole - an immunohistochemical study. Histpathology 1995;27:341-7.
28. Nishi H, Yahata N, Ohyashiki K et al. Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases. Int J Oncol 1998;12:81-5.
29. Bae SN, Kim SJ. Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol 1999;180:328-33.
30. Sukcharoen N, Mutirangura A, Limpongsanurak S. Telomerase activity in complete hydatidiform mole. J Reprod Med 1999;44:465-70.
31. Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol 1999;52:588-92.
32. Lehner R, Bobak J, Kim NW, Shroyer AL, Shroyer KR. Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynecol 2001;97:965-70.
33. Amezcua CA, Bahador A, Naidu YM, Felix JC. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles. Am J Obstet Gynecol 2001;184:1441-6.
34. Chen RJ, Chu CT, Huang SC, Chow SN, Hsieh CY. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod 2002;17:463-8.
35. Counter CM, Gupta J, Harely CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in haematologic malignancies. Blood 1995;14:423-33.